Obstetrics & gynecology
Women’s health & pregnancy clinical trials
Reproductive health, pregnancy, and conditions specific to women. We’re tracking 6,073 recruiting studies in this area right now.
By phase
- Not applicable4,179
- Phase 2597
- Phase 1410
- Phase 3326
- Phase 4250
- Phase 1/Phase 2245
- Phase 2/Phase 366
Top conditions
- Ovarian Cancer336
- Cervical Cancer223
- Endometrial Cancer206
- Bladder Cancer186
- Acute Kidney Injury134
- Endometriosis132
- Pregnancy128
- Chronic Kidney Diseases122
- Breast Cancer110
- Chronic Kidney Disease107
- Infertility92
- Renal Cell Carcinoma80
- Colorectal Cancer77
- Preeclampsia71
- Prostate Cancer68
- Pregnancy Related65
- Hypertension60
- Urinary Incontinence60
Leading sponsors
- Mayo Clinic60
- IRCCS Azienda Ospedaliero-Universitaria di Bologna47
- M.D. Anderson Cancer Center45
- Assistance Publique - Hôpitaux de Paris44
- Fondazione Policlinico Universitario Agostino Gemelli IRCCS44
- National Cancer Institute (NCI)41
- AstraZeneca37
- University of Colorado, Denver37
- University of Aarhus35
- Chinese University of Hong Kong33
Where studies are running
- California348
- Alabama153
- Texas119
- Massachusetts117
- New York115
- Arizona106
- Florida103
- Maryland88
- Colorado85
- Illinois79
Recruiting studies6,073 total
- NCT06209346Recruiting
Remote physical therapy for chronic pelvic pain from endometriosis
This trial tests if a physical therapy program done at home through video calls can help reduce chronic pelvic pain in people with endometriosis. If you have ongoing pelvic pain and have already had medical or surgical treatment, this study may offer a new way to manage your pain.
Alcalà de Henares, MadridAges 18–55 - NCT06209294RecruitingPhase 2
New drug combo before fertility-sparing surgery for cervical cancer
This trial tests a combination of immunotherapy (AK104) and standard chemotherapy before surgery for a certain type of early-stage cervical cancer. The goal is to see if this approach can help shrink the tumor enough to allow fertility-preserving surgery, so you may be able to keep your uterus.
Shanghai, Shanghai MunicipalityAges 18–45 - NCT03111173Recruiting
Check if a standard ECG can record your baby’s heart activity
This study tests whether a routine heart recording test (ECG) can capture fetal (baby) heart activity during late pregnancy. It may help researchers find simpler ways to monitor baby heart rhythm without special equipment.
Seattle, WashingtonAges 18–55 - NCT06058078RecruitingPhase 2
Cell therapy for active lupus nephritis
This trial tests a new cell therapy (RY_SW01) for people with active lupus nephritis (kidney inflammation caused by lupus) who haven't responded well to standard treatments. It aims to see if the therapy can help control the disease.
Nanjing, JiangsuAges 18–65 - NCT05969041RecruitingPhase 1
Early-phase drug trial for advanced epithelial cancers
This Phase 1 study tests a new drug (MT-302) in adults with advanced or metastatic epithelial cancers that have worsened or stopped responding to standard treatment. The goal is to see how the drug works and whether it is safe for people with limited options.
Darlinghurst, New South WalesAges 18 years+ - NCT06211790RecruitingPhase 2
Targeted first-line treatment for advanced kidney cancer based on protein profile
This trial tests a first-line precision treatment for clear cell kidney cancer that has spread or cannot be removed. It aims to match the treatment to your cancer's protein profile to improve outcomes.
ShanghaiAges 18–75 - NCT06215950RecruitingPhase 1
CAR-T cell therapy for advanced gynecologic cancer with CD70 protein
This trial tests a new treatment called CAR-T cells that target a protein called CD70 found on some gynecologic cancer cells. It is for people whose cancer has advanced or spread and has not responded to or stopped responding to standard treatments.
Wuhu, AnhuiAges 18 years+ - NCT05452291Recruiting
Testing multi-sample biomarkers for recurring kidney stones
This study looks for “biomarkers,” which are measurable signs in samples like urine or blood, to help understand and detect recurring urinary stone disease. It may help future patients by improving how doctors predict stone recurrence or identify stone types.
ShatinAges 18 years+ - NCT06215352Recruiting
Meal timing and blood sugar during pregnancy
This study looks at how when and what you eat during early pregnancy affects your blood sugar levels. It may help find ways to improve glucose control for expecting mothers.
Taipei, Zhongzheng DistrictAges 20 years+ - NCT05746897RecruitingPhase 1
First-in-human test of an anti-PVRIG drug for advanced cancers
This early-phase study tests NM1F (an anti-PVRIG antibody) in people with advanced solid tumors to see if it’s safe and whether it may work. It also includes pembrolizumab (a PD-1 “checkpoint” medicine), aiming to boost the immune system against the cancer.
Dallas, TexasAges 18 years+ - NCT03414827Recruiting
Genetic testing study for kidney cancer
This study looks at genetic features of kidney cancer by testing tumor samples. The goal is to find biomarkers—specific signs—that may help predict what kind of kidney cancer it is.
RoskildeAges Any age - NCT06229522Recruiting
Organoids to personalize ovarian cancer treatment
This study uses lab-grown tumor models (organoids) from your tissue or fluid sample to find the best treatment for your ovarian cancer.
Aviano, PordenoneAges 18 years+ - NCT05060783Recruiting
Liquid blood test to help detect kidney cancer
This study tests whether a “liquid biopsy” blood test can help detect kidney cancer when a CT scan looks suspicious but does not show cancer. It may help avoid unnecessary procedures or catch cancer patterns earlier, but it will depend on the type of kidney tumor and your situation.
RoskildeAges 18 years+ - NCT03857373Recruiting
Study testing a computer tool to detect kidney cancer after surgery
This trial is for people with renal (kidney) cancer who have already had surgery. The study is testing whether a computer method can use medical information from you to improve kidney-cancer detection.
RoskildeAges Any age - NCT06144268Recruiting
Sperm selection for intrauterine insemination
This trial tests a device called ZyMōt Multi that selects the best sperm for intrauterine insemination (IUI). It may help couples trying to conceive by improving the chance of a live birth.
BrusselsAges 18–36 - NCT06232122Recruiting
New PET scans to detect ovarian cancer recurrence
This study uses two types of PET/CT scans (68Ga-FAPI-46 and 18F-FDG) to look for any returning ovarian cancer. The goal is to find recurrence early so you and your doctor can plan the next steps.
Taoyuan CityAges 30–80 - NCT03225586Recruiting
Study of health differences in urban and rural communities
This study enrolls consenting adults to understand how health differs between people living in cities versus rural areas. Your participation may help researchers learn what factors influence health over time.
Rosario, Santa Fe ProvinceAges 35–70 - NCT06239909Recruiting
Adjustable sphincter for urine leakage after prostate surgery
This trial is testing an adjustable artificial sphincter called Victo to help men who leak urine after prostate surgery. It may improve bladder control and quality of life.
Ostrava, Moravian-Silesian RegionAges 18 years+ - NCT05952947RecruitingPhase 1
Study drug for HPV18-positive solid tumors with a specific immune marker
This Phase 1 trial tests HRYZ-T101 injection for people whose solid cancer is HPV18-positive and who have the HLA-DRB1*0901 immune marker. It is meant for people whose cancer has returned or spread and who have few or no effective treatment options.
Shanghai, Shanghai MunicipalityAges 18–75 - NCT05753826RecruitingPhase 2
Study of two medicines for platinum-resistant ovarian cancer
This Phase 2 trial studies whether adding adebrelimab to fuzuloparib can help people with ovarian cancer that comes back quickly after platinum chemotherapy. It is aimed especially at tumors with a specific DNA-repair gene (HRR mutation).
FujianAges 18–70 - NCT05983276RecruitingPhase 2
Combination therapy for drug-resistant ovarian cancer
This trial tests a new two-drug combination (decitabine and selinexor) given with standard chemotherapy to see if it can reverse drug resistance in ovarian cancer that has come back or worsened after treatment.
Maywood, IllinoisAges 18 years+ - NCT04282044RecruitingPhase 1
CRX100 drug trial for advanced cancers with or without pembrolizumab
This Phase 1 trial tests CRX100 (a new cancer medicine) alone and with pembrolizumab (an immune checkpoint drug) in people with advanced solid tumors. It’s mainly designed to check safety and side effects, and to see whether tumors respond, potentially helping people whose cancer has come back or stopped responding to standard treatment.
Scottsdale, ArizonaAges 18 years+ - NCT06249308Recruiting
Liquid biopsy test for early ovarian cancer detection
This study is testing a blood test to see if it can catch ovarian cancer early. You may be eligible if you have been recently diagnosed with ovarian cancer and haven't started treatment yet.
Guangzhou, GuangdongAges 40–75 - NCT07874191Recruiting
Eye blood flow study in pregnant women with preeclampsia
This study uses a special eye scan to compare blood flow in the back of the eye between pregnant women with preeclampsia, healthy pregnant women, and healthy non-pregnant women. The goal is to see if preeclampsia affects eye blood vessels, which might help with early detection.
Muğla, MenteşeAges 18–45
Common questions
- How many women’s health & pregnancy clinical trials are recruiting?
- Clin2 is tracking 6,073 recruiting obstetrics & gynecology studies from the U.S. registry right now, out of 9,800 we cover in this area in total.
- What does “Women’s health & pregnancy” cover here?
- Reproductive health, pregnancy, and conditions specific to women. We group each study into women’s health & pregnancy based on the conditions it studies, so you can scan the whole therapeutic area at once and drill into a specific condition.
- How do I find a women’s health & pregnancy trial near me?
- Use the search to filter women’s health & pregnancy studies by location and eligibility. Every Clin2 trial page explains the criteria in plain English and offers a short, optional pre-screen for a fit read — the study team makes the final decision.
Other specialties
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov; specialty groupings are derived from each study’s conditions. Talk with your doctor about whether a specific trial is right for you.